DeepDx
Prostate - CNB
AI software for prostate cancer
- Description
- DeepDx Prostate is a clinically validated and CE-marked AI diagnostic support software for prostate cancer. The software analyzes digitized slide images of Hematoxylin & Eosin (H&E) stained prostate specimens to detect and localize areas of interest. These areas of interest are detected based on their severity in accordance with the Gleason Scoring System.
Key Features
-
01
- Approved by Korea MFDS, and CE marked
-
02
- Procedure Type
- Needle biopsy, TURP and Prostatectomy (Coming Soon)
-
03
- Extensively Tested
- 700k+ cores analyzed
-
04
- Versatile Deployment
- Cloud & On-Premise
- 01AI-based diagnostics support
- AI analysis includes ROI detection, Gleason scores, grade group, and quantification of important matrix.
- 02Fast and Accurate
- It takes 30 seconds to run the AI analysis (per core), and improves accuracy with 99% sensitivity and 97% specificity.
- 03Research-Based
- DeepDx Prostate validation studies were published in prestigious peer-reviewed medical journals including Cancers and npj Digital Medicine.
- 04Consistency
- DeepDx Prostate generates consistency as a diagnostics support software.
Key Functions & Featuress
- Colored Overlays
- DeepDx Prostate generates three different colored overlays based on the Gleason patterns 3, 4, and 5.
- Tumor & Pattern Quantification
- The proportions of each Gleason pattern out of the total tumor area and tumor-to-tissue ratios are automatically quantified.
- Real-time Modification
- Quantitative metrics such as tumor-to-tissue ratios and Gleason pattern ratios are recalculated in real time as annotations are made.
- Annotation Tools
- Annotation tools allow the user to modify the AI analysis results. Automatic measurements of total tissue and total tumor lengths are also generated.
DeepDx Prostate can be used in a variety of use settings including first read, concurrent read, quality control, research and development, and education.